Compare Stocks → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison OTCMKTS:CTTCNASDAQ:NVIVNASDAQ:SINTOTCMKTS:UAHC Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCTTCCalmare Therapeutics$0.00$0.00▼$0.02N/AN/AN/AN/ANVIVInVivo Therapeutics$0.58$0.22▼$2.40$997K0.658.25 million shs1.89 million shsSINTSintx Technologies$0.04+4.5%$0.10$0.02▼$2.13$948K1.4621.40 million shs107.34 million shsUAHCUnited American Healthcare$0.03-21.5%$0.03$0.02▼$0.05$3.11M-1.422,737 shs1,200 shs13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCTTCCalmare Therapeutics0.00%0.00%0.00%0.00%0.00%NVIVInVivo Therapeutics0.00%0.00%0.00%-56.07%-76.93%SINTSintx Technologies+7.24%+60.64%-69.23%-86.48%-98.09%UAHCUnited American Healthcare+2.31%+2.31%+6.40%+20.36%+66.25%SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCTTCCalmare TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ANVIVInVivo TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ASINTSintx TechnologiesN/AN/AN/AN/AN/AN/AN/AN/AUAHCUnited American HealthcareN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCTTCCalmare TherapeuticsN/AN/AN/AN/ANVIVInVivo TherapeuticsN/AN/AN/AN/ASINTSintx Technologies2.00HoldN/AN/AUAHCUnited American HealthcareN/AN/AN/AN/ACurrent Analyst RatingsLatest NVIV, UAHC, SINT, and CTTC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails2/5/2024SINTSintx TechnologiesMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCTTCCalmare TherapeuticsN/AN/AN/AN/AN/AN/ANVIVInVivo TherapeuticsN/AN/AN/AN/A$6.48 per shareN/ASINTSintx Technologies$2.63M0.36N/AN/A$1.65 per share0.03UAHCUnited American HealthcareN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCTTCCalmare TherapeuticsN/AN/A0.00N/AN/AN/AN/AN/AN/ANVIVInVivo Therapeutics-$10.49MN/A0.00N/AN/AN/A-75.04%-65.01%N/ASINTSintx Technologies-$8.26M-$3.42N/A∞N/A-314.39%-67.12%-45.49%5/20/2024 (Estimated)UAHCUnited American HealthcareN/AN/A0.00∞N/AN/AN/AN/AN/ALatest NVIV, UAHC, SINT, and CTTC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/27/2024Q4 2023SINTSintx TechnologiesN/A-$0.09-$0.09-$0.09N/A$0.90 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCTTCCalmare TherapeuticsN/AN/AN/AN/AN/ANVIVInVivo TherapeuticsN/AN/AN/AN/AN/ASINTSintx TechnologiesN/AN/AN/AN/AN/AUAHCUnited American HealthcareN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCTTCCalmare TherapeuticsN/AN/AN/ANVIVInVivo TherapeuticsN/A14.3014.30SINTSintx TechnologiesN/A1.901.60UAHCUnited American HealthcareN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipCTTCCalmare TherapeuticsN/ANVIVInVivo Therapeutics13.78%SINTSintx Technologies18.38%UAHCUnited American HealthcareN/AInsider OwnershipCompanyInsider OwnershipCTTCCalmare Therapeutics17.50%NVIVInVivo Therapeutics2.45%SINTSintx Technologies1.00%UAHCUnited American Healthcare14.31%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCTTCCalmare Therapeutics7N/AN/ANot OptionableNVIVInVivo Therapeutics63.11 million3.03 millionNot OptionableSINTSintx Technologies4122.68 million22.45 millionNot OptionableUAHCUnited American Healthcare33117.06 million100.31 millionNot OptionableNVIV, UAHC, SINT, and CTTC HeadlinesSourceHeadlineDow's 265-point rally led by gains in shares of American Express, UnitedHealthmarketwatch.com - April 19 at 1:29 PMNational Minority Health Month; bringing awareness to health disparities and encouraging actionmsn.com - April 19 at 8:27 AMUnited American Healthcare (OTCMKTS:UAHC) Stock Price Crosses Below 200 Day Moving Average of $0.03americanbankingnews.com - April 19 at 4:04 AM$2M going to United Health Centers for physician training, retentionthebusinessjournal.com - April 17 at 6:41 PMUnitedHealth skips hearing in the wake of Change cyberattack, triggering call for subpoenastatnews.com - April 17 at 6:41 PMNew Phase Of Change Healthcare Attack Begins As Hackers Leak Datakffhealthnews.org - April 16 at 3:25 PMUnitedHealth says Change Healthcare cyberattack cost it $872 millionmsn.com - April 16 at 3:25 PMHacker gang claims it has Change Healthcare data from cyberattackbizjournals.com - April 15 at 8:09 AMKeep Alachua County Beautiful hosts 33rd annual ‘Great American Cleanup’msn.com - April 14 at 2:06 AMCrippling Cyberattack Brings U.S. HealthCare System to a Halttownhall.com - April 13 at 12:46 AM2024 American Lung Association’s Fight for Air Climbwgnradio.com - April 12 at 9:45 AMHuge health care hack exposed 144M Americans' info. Was your data exposed? Check heremsn.com - April 11 at 7:10 PMApril is National Minority Health Monthjournal-advocate.com - April 11 at 9:10 AMAMA: Four In Five Physicians ‘Lost Revenue’ From Change Healthcare Cyber Attackforbes.com - April 10 at 2:41 PMAMA: Four In Five Physicians ‘Lost Revenue’ From Change Healthcare Cyber Attackforbes.com - April 10 at 2:41 PMChange Healthcare Could Get Congress’ Attention Before Break for Electionajmc.com - April 6 at 8:24 PMUnited Healthcare Colorado: Recognize health disparities in racial and ethnic minority groupsgreeleytribune.com - April 3 at 10:51 AMUS Healthcare BPO Market Share and Industry Trends (2019-2029) Featuring UnitedHealth Group, Cognizant, Accenture, Genpact, IBM, and Morefinance.yahoo.com - April 2 at 3:26 PMChange Healthcare cyberattack: Where do things stand?msn.com - March 29 at 11:23 PMOregon health care providers still feeling cash crunch after national hack endsopb.org - March 29 at 1:21 PM4 Things You Need to Know About Health Care Cyberattacksnytimes.com - March 29 at 1:21 PMSteward Health Care selling major part of operations to Optum Caremsn.com - March 28 at 7:14 AMUnitedHealth Group Pays $3 billion To Providers After Cyberattacktechbullion.com - March 28 at 7:14 AMMass. Sens. Warren, Markey push back against Steward, United proposalmsn.com - March 27 at 9:12 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsCalmare TherapeuticsOTCMKTS:CTTCCalmare Therapeutics Incorporated, a medical device company, develops and commercializes products and technologies for chronic neuropathic pain and wound care affliction patients in the United States. Its flagship medical device is Calmare Pain Therapy Device, a non-invasive and non-addictive modality for the treatment of chronic and neuropathic pain. The company was formerly known as Competitive Technologies, Inc. and changed its name to Calmare Therapeutics Incorporated in August 2014. Calmare Therapeutics Incorporated was founded in 1968 and is based in Fairfield, Connecticut.InVivo TherapeuticsNASDAQ:NVIVInVivo Therapeutics Holdings Corp. operates as a research and clinical-stage biomaterials and biotechnology company in the United States. The company engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant comprise of biocompatible and bioresorbable polymers, which includes Poly lactic-co-glycolic acid, a polymer which is widely used in resorbable sutures and provides the biocompatible support for Neuro-Spinal Scaffold implant; and Poly-L-Lysine, a positively charged polymer used to coat surfaces to promote cellular attachment. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts. On February 1, 2024, InVivo Therapeutics Holdings Corp. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. It is in joint administration with InVivo Therapeutics Corporation.Sintx TechnologiesNASDAQ:SINTSintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.United American HealthcareOTCMKTS:UAHCUnited American Healthcare Corporation, through its subsidiaries, provides contract manufacturing services to the medical device industry. It also focuses on the production of natural rubber. The company was incorporated in 1983 and is based in Chicago, Illinois. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.